ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,424.20
0.05%
Dow Jones
39,806.77
-0.49%
Gold vs US Dollar
2,427.41
0.32%
Brent Oil
83.53
-0.08%
Bitcoin
69,820.66
5.35%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) News

Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KNSA
DateTimeSourceHeadlineSymbolCompany
07/05/202421:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
23/04/202412:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
16/04/202421:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/04/202412:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Announces Development Indication for AbiprubartNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
05/03/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
05/03/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
01/03/202422:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
29/02/202421:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202412:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
27/02/202422:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
21/02/202421:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
14/02/202421:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
14/02/202420:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/01/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/01/202412:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/01/202412:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate UpdateNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
03/01/202421:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/01/202421:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
11/12/202321:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/12/202321:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/11/202320:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
31/10/202311:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
31/10/202311:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
24/10/202321:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/09/202300:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/09/202300:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/09/202300:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/09/202300:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
05/09/202322:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:KNSA

Your Recent History

HITB
GSTETH
GrEARN Token
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved